ArticleEnvironmental health perspectives2010
The case for a global ban on asbestos.
Article in Environmental health perspectives, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
52 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- Examining the Environmental Ramifications of Asbestos Fiber Movement Through the Water-Soil Continuum: A Review.International journal of environmental research and public health · 2025Pooled it
- Prostate Cancer and Asbestos: A Systematic Review and Meta-Analysis.The Permanente journal · 2020Pooled it
- Serum mesothelin for diagnosing malignant pleural mesothelioma: an individual patient data meta-analysis.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2012Pooled it
- Circulating microRNA-197-3p as a potential biomarker for asbestos exposure.Scientific reports · 2021Trial
- Burden of cancer attributable to six occupational exposures in the Netherlands, 2021: a health impact assessment study.BMJ public health · 2026Article
- The transparency and public availability of asbestos exposure levels.Journal of thoracic disease · 2025Review
- Traditional medicine, environmental exposures, and cultural practices in cancer risk: insights from low- and middle-income countries.Frontiers in oncology · 2025Review
- Burden of laryngeal cancer attributable to occupational asbestos exposure in China: A comprehensive analysis from 1990 to 2021.PloS one · 2025Article
- Challenges in Identifying and Diagnosing Asbestos-Related Diseases in Emerging Economies: A Global Health Perspective.Annals of global health · 2025Review
- Evaluation of asbestos dispersion during laser ablation of rocks containing Naturally Occurring Asbestos (NOA).Heliyon · 2024Article
- The aftermath of asbestos prohibition in industry and its association with malignant mesothelioma in the south of Iran: An enduring predicament yet to be resolved.Health science reports · 2024Article
- Plants, Microorganisms and Their Metabolites in Supporting Asbestos Detoxification-A Biological Perspective in Asbestos Treatment.Materials (Basel, Switzerland) · 2024Review
- Molecular and Cellular Mechanism of Action of Chrysotile Asbestos in MRC5 Cell Line.Journal of personalized medicine · 2023Article
- Microbe-Mineral Interactions between Asbestos and Thermophilic Chemolithoautotrophic Anaerobes.Applied and environmental microbiology · 2023Article
- Article
- Asbestos awareness among the residents of St. Kitts and Nevis: a cross-sectional study.Globalization and health · 2022Article
- Analysis of Mortality from Asbestos-Related Diseases in Brazil Using Multiple Health Information Systems, 1996-2017.Safety and health at work · 2022Article
- Review
- Challenging Global Waste Management - Bioremediation to Detoxify Asbestos.Frontiers in environmental science · 2020Article
- Nivolumab-induced immune thrombocytopenia in a patient with malignant pleural mesothelioma.Respiratory medicine case reports · 2020Article
Corrections and comments
- Commented on by
- Commented on by
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAll forms of asbestos are now banned in 52 countries. Safer products have replaced many materials that once were made with it. Nonetheless, many countries still use, import, and export asbestos and asbestos-containing products, and in those that have banned other forms of asbestos, the so-called "controlled use" of chrysotile asbestos is often exempted from the ban. In fact, chrysotile has accounted for > 95% of all the asbestos used globally.
objectiveWe examined and evaluated the literature used to support the exemption of chrysotile asbestos from the ban and how its exemption reflects the political and economic influence of the asbestos mining and manufacturing industry. DISCUSSION: All forms of asbestos, including chrysotile, are proven human carcinogens. All forms cause malignant mesothelioma and lung and laryngeal cancers, and may cause ovarian, gastrointestinal, and other cancers. No exposure to asbestos is without risk. Illnesses and deaths from asbestos exposure are entirely preventable.
conclusionsAll countries of the world have an obligation to their citizens to join in the international endeavor to ban the mining, manufacture, and use of all forms of asbestos. An international ban is urgently needed. There is no medical or scientific basis to exempt chrysotile from the worldwide ban of asbestos.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.